Guest guest Posted May 28, 2007 Report Share Posted May 28, 2007 > , > This leads me to ask what about phages? Any thoughts? > > a Carnes > Phage, enzymes, and other large-molecules all have some common limitations. They are likely to provoke antibodies in some cases, which can inactivate them or even cause hairy reactions. They also may not be too easy to target to cytosol, which sometimes matters, sometimes not. But, there's at least some hope. Lot of people are working on antibacterial peptides from macro-organisms. Actually, they have been for a while. Why none of their molecules have really hit the clinic, I don't know. One idea that's been thought of is maybe just pull one of the old drugs out of the clinic. In time (decades), populations of Sa and other resistance-gathering organisms may regain sensitivity to the disused molecule. This may not happen, though, for every drug. It's only gonna happen if the resistance-conferring mutation confers some kind of small or very small, but non-infinitessimal, disadvantage. We'll definitely have to figure out something. Quote Link to comment Share on other sites More sharing options...
Recommended Posts
Join the conversation
You are posting as a guest. If you have an account, sign in now to post with your account.
Note: Your post will require moderator approval before it will be visible.